Differential sensitivity of presynaptic and postsynaptic GABAB receptors in rat ventrolateral periaqueductal gray. 2017

Qian Chen, and Caifeng Shao, and Hui Zhou, and Rui Ma, and Ping Jiang, and Kun Yang
Departments of aAnatomy bClinical Laboratory, School of Medicine, Jiangsu University cDepartment of Anesthesiology, Affiliated People's Hospital of Jiangsu University dElectrophysiology Laboratory, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.

The ventrolateral periaqueductal gray (PAG) in the midbrain plays a key role in the descending pain modulatory system. γ-Aminobutyric acid type B (GABAB) receptors belong to a metabotropic receptor subfamily and mediate both presynaptic and postsynaptic effects in PAG. It has been well documented that activation of GABAB receptors yields analgesia in some PAG subdivisions. In the present study, employing whole-cell patch-clamp recordings on acute rat PAG slices, we simultaneously monitored the responses of presynaptic and postsynaptic GABAB receptors. We found that the GABAB agonist, baclofen, exhibits less efficacy and potency at GABAB postsynaptic versus presynaptic receptors. This sensitivity bias may contribute to synapse homeostasis and implicate a novel pharmacotherapy treatment.

UI MeSH Term Description Entries
D008297 Male Males
D010487 Periaqueductal Gray Central gray matter surrounding the CEREBRAL AQUEDUCT in the MESENCEPHALON. Physiologically it is probably involved in RAGE reactions, the LORDOSIS REFLEX; FEEDING responses, bladder tonus, and pain. Mesencephalic Central Gray,Midbrain Central Gray,Central Gray Substance of Midbrain,Central Periaqueductal Gray,Griseum Centrale,Griseum Centrale Mesencephali,Periaqueductal Gray Matter,Substantia Grisea Centralis,Substantia Grisea Centralis Mesencephali,Central Gray, Mesencephalic,Central Gray, Midbrain,Gray Matter, Periaqueductal,Gray, Central Periaqueductal,Griseum Centrale Mesencephalus,Periaqueductal Grays, Central
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001418 Baclofen A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission. Baclophen,Chlorophenyl GABA,Apo-Baclofen,Atrofen,Ba-34,647,Ba-34647,Baclofen AWD,Baclofène-Irex,Baclospas,CIBA-34,647-BA,Clofen,Gen-Baclofen,Genpharm,Lebic,Lioresal,Liorésal,Nu-Baclo,PCP-GABA,PMS-Baclofen,beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid,beta-(p-Chlorophenyl)-gamma-aminobutyric Acid,AWD, Baclofen,Apo Baclofen,ApoBaclofen,Ba34,647,Ba34647,Baclofène Irex,BaclofèneIrex,CIBA34,647BA,GABA, Chlorophenyl,Gen Baclofen,GenBaclofen,Nu Baclo,NuBaclo,PMS Baclofen,PMSBaclofen
D013569 Synapses Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions. Synapse
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D017729 Presynaptic Terminals The distal terminations of axons which are specialized for the release of neurotransmitters. Also included are varicosities along the course of axons which have similar specializations and also release transmitters. Presynaptic terminals in both the central and peripheral nervous systems are included. Axon Terminals,Nerve Endings, Presynaptic,Synaptic Boutons,Synaptic Terminals,Axon Terminal,Bouton, Synaptic,Boutons, Synaptic,Ending, Presynaptic Nerve,Endings, Presynaptic Nerve,Nerve Ending, Presynaptic,Presynaptic Nerve Ending,Presynaptic Nerve Endings,Presynaptic Terminal,Synaptic Bouton,Synaptic Terminal,Terminal, Axon,Terminal, Presynaptic,Terminal, Synaptic,Terminals, Axon,Terminals, Presynaptic,Terminals, Synaptic
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D058786 GABA-B Receptor Agonists Endogenous compounds and drugs that bind to and activate GABA-B RECEPTORS. GABA-B Agonists,GABA-B Receptor Agonist,Agonist, GABA-B Receptor,Agonists, GABA-B,Agonists, GABA-B Receptor,GABA B Agonists,GABA B Receptor Agonist,GABA B Receptor Agonists,Receptor Agonist, GABA-B,Receptor Agonists, GABA-B

Related Publications

Qian Chen, and Caifeng Shao, and Hui Zhou, and Rui Ma, and Ping Jiang, and Kun Yang
August 2012, Brain research bulletin,
Qian Chen, and Caifeng Shao, and Hui Zhou, and Rui Ma, and Ping Jiang, and Kun Yang
May 2013, Neuroscience letters,
Qian Chen, and Caifeng Shao, and Hui Zhou, and Rui Ma, and Ping Jiang, and Kun Yang
March 2003, Biochemical and biophysical research communications,
Qian Chen, and Caifeng Shao, and Hui Zhou, and Rui Ma, and Ping Jiang, and Kun Yang
September 2003, The Journal of comparative neurology,
Qian Chen, and Caifeng Shao, and Hui Zhou, and Rui Ma, and Ping Jiang, and Kun Yang
July 1993, Journal of neurophysiology,
Qian Chen, and Caifeng Shao, and Hui Zhou, and Rui Ma, and Ping Jiang, and Kun Yang
January 2013, Neural plasticity,
Qian Chen, and Caifeng Shao, and Hui Zhou, and Rui Ma, and Ping Jiang, and Kun Yang
June 2010, European journal of pharmacology,
Qian Chen, and Caifeng Shao, and Hui Zhou, and Rui Ma, and Ping Jiang, and Kun Yang
August 2010, European journal of pharmacology,
Qian Chen, and Caifeng Shao, and Hui Zhou, and Rui Ma, and Ping Jiang, and Kun Yang
February 2001, The Journal of comparative neurology,
Qian Chen, and Caifeng Shao, and Hui Zhou, and Rui Ma, and Ping Jiang, and Kun Yang
April 2000, The Journal of comparative neurology,
Copied contents to your clipboard!